| Efficacy is not everything: eliciting women’s preferences for a vaginal HIV prevention product using a discrete-choice experiment EN Browne, ET Montgomery, C Mansfield, M Boeri, B Mange, ... AIDS and Behavior 24, 1443-1451, 2020 | 30 | 2020 |
| Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best–worst scaling experiment in caregivers and adult patients RS Paquin, R Fischer, C Mansfield, B Mange, K Beaverson, A Ganot, ... Orphanet journal of rare diseases 14, 1-9, 2019 | 28 | 2019 |
| Parkinson’s patients’ tolerance for risk and willingness to wait for potential benefits of novel neurostimulation devices: a patient-centered threshold technique study B Hauber, B Mange, M Zhou, S Chaudhuri, HL Benz, B Caldwell, JP Ruiz, ... MDM policy & practice 6 (1), 2381468320978407, 2021 | 26 | 2021 |
| Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey A Brett Hauber, B Mange, MA Price, D Wolin, M Bensink, JA Kaye, ... Supportive Care in Cancer 26, 251-260, 2018 | 18 | 2018 |
| From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices M Boeri, B Szegvari, B Hauber, B Mange, I Mountian, M Schiff, ... Patient preference and adherence, 1093-1110, 2019 | 14 | 2019 |
| Patient and physician preferences for multiple sclerosis treatments in Germany: a discrete-choice experiment study C Poulos, C Wakeford, E Kinter, B Mange, T Schenk, M Jhaveri Multiple Sclerosis Journal–Experimental, Translational and Clinical 6 (1 …, 2020 | 13 | 2020 |
| Numbers JP Lange Christian Classics Reproductions, 2023 | 11 | 2023 |
| Patients’ and caregivers’ maximum acceptable risk of death for non‐curative gene therapy to treat Duchenne muscular dystrophy HL Peay, R Fischer, B Mange, RS Paquin, EC Smith, A Sadosky, L Russo, ... Molecular genetics & genomic medicine 9 (5), e1664, 2021 | 9 | 2021 |
| Patient-centered identification of meaningful regulatory endpoints for medical devices to treat Parkinson’s disease HL Benz, B Caldwell, JP Ruiz, A Saha, M Ho, S Christopher, D Bardot, ... MDM Policy & Practice 6 (1), 23814683211021380, 2021 | 8 | 2021 |
| Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment BJ Patterson, K Myers, A Stewart, B Mange, EM Hillson, C Poulos Expert review of vaccines 20 (6), 729-741, 2021 | 7 | 2021 |
| Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease SE Chaudhuri, Z Ben Chaouch, B Hauber, B Mange, M Zhou, ... Journal of Biopharmaceutical Statistics, 1-20, 2023 | 6 | 2023 |
| Patient treatment preferences for relapsed/refractory multiple myeloma: are patients willing to trade off efficacy for tolerability? D Auclair, C Mansfield, A Chari, CE Cole, MA Fiala, JL Kaufman, G Orloff, ... Blood 132, 614, 2018 | 6 | 2018 |
| Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany SR Feldman, C Poulos, I Gilloteau, B Mange, K Boehm, M Boeri, M Naatz, ... Journal of Dermatological Treatment 33 (3), 1511-1520, 2022 | 5 | 2022 |
| Preferences and priorities for relapsed multiple myeloma treatments among patients and caregivers in the United States D Auclair, C Mansfield, MA Fiala, A Chari, CE Cole, JL Kaufman, GJ Orloff, ... Patient preference and adherence, 573-585, 2022 | 5 | 2022 |
| Career interruption and productivity: evidence from major league baseball during the Vietnam War Era B Mange, DC Phillips Journal of Human Capital 10 (2), 159-185, 2016 | 4 | 2016 |
| Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: Results from a national patient advocacy survey. M Price, A Ravelo, M Sae-Hau, PA Torney, V Gonzalez, ES Weiss, ... Journal of Clinical Oncology 37 (15_suppl), e18198-e18198, 2019 | 3 | 2019 |
| Understanding the preferences of patients and caregivers for relapsed/refractory multiple myeloma treatment: a mixed-mode patient-centric approach D Auclair, C Mansfield, A Chari, CE Cole, MA Fiala, JL Kaufman, G Orloff, ... Blood 130, 5662, 2017 | 2 | 2017 |
| Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2. 8-008) K Gwinn, S Chaudhuri, A Hauber, B Mange, H Benz, B Caldwell, A Saha, ... Neurology 92 (15 Supplement), 2019 | 1 | 2019 |
| Patient-Reported Disease Burden and Age: Results from a National Patient Advocacy Survey of Patients with Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma and … KL Dawson, MA Price, PA Torney, V Gonzalez, M Sae-Hau, ES Weiss, ... Blood 134, 4778, 2019 | | 2019 |
| 2656. Eliciting Preferences for Zoster Vaccination in US Adults Aged 50 Years and Older. BJ Patterson, K Meyers, A Stewart, B Mange, EM Hillson, S Cyr, C Poulos Open Forum Infectious Diseases 6, 2019 | | 2019 |
